Months before the US Food and Drug Administration even authorized the first Covid-19 vaccine, there were many conversations and debates going on about who should be put at the front of the line to get it. Different advisory panels and patient advocacy groups came out with suggested recommendations.
At the time, it all seemed so logical. But soon after the first vaccines were authorized by the FDA, things started to become a bit confusing.
Papildomos nuorodos
